BNT162b2信使RNA新冠疫苗接种后多系统炎症与器官功能障碍
本文报告一例20岁既往健康男性大学生在接种首剂BNT162b2信使RNA新冠疫苗后不久出现耳鸣和血尿,迅速进展为系统性炎症、需血液透析的急性肾损伤、急性双侧完全性感音神经性听力丧失、影像学证实的急性多灶性缺血性卒中、心包积液并心脏压塞需心包引流、需引流的胸腔积液及系统性毛细血管渗漏。包括细胞因子分析、全血飞行时间流式细胞术和全外显子组测序在内的广泛临床与研究检查未发现明确的解释机制。作者指出该疫苗总体安全性仍然优秀,但已有罕见严重事件报告。
要点
- 20岁既往健康男性接种首剂BNT162b2疫苗后不久出现耳鸣和血尿,随后迅速进展为多系统炎症与器官功能障碍。
- 临床表现为需血液透析的急性肾损伤、急性双侧完全性感音神经性听力丧失、急性多灶性缺血性卒中、心包积液并心脏压塞需心包引流及胸腔积液需引流。
- 细胞因子分析、全血飞行时间流式细胞术和全外显子组测序均未揭示明确的解释机制。
- 作者指出该疫苗对一般人群的总体安全性仍然优秀,但已有罕见严重事件报告。
适用人群与场景
- 既往健康的20岁男性大学生,接种首剂BNT162b2信使RNA新冠疫苗后不久发病。
红旗征与不能漏的情况
- 接种后出现系统性炎症、急性肾损伤需血液透析、急性双侧完全性感音神经性听力丧失、急性多灶性缺血性卒中、心包积液并心脏压塞需心包引流、胸腔积液需引流、系统性毛细血管渗漏。
研究设计与关键结果
- 病例报告:20岁既往健康男性大学生接种首剂BNT162b2疫苗后不久出现耳鸣和血尿,迅速进展为系统性炎症、需血液透析的急性肾损伤、急性双侧完全性感音神经性听力丧失、影像学证实的急性多灶性缺血性卒中、心包积液并心脏压塞需心包引流、需引流的胸腔积液及系统性毛细血管渗漏。
- 细胞因子分析、全血飞行时间流式细胞术和全外显子组测序未发现明确的解释机制。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者指出,BNT162b2新冠疫苗对一般人群的总体安全性仍然优秀,但已有罕见严重事件报告;本报告描述了一例机制未明的多系统炎症与器官功能障碍,未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: The U.S. Food and Drug Administration has to date granted approval or emergency use authorization to three vaccines against severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019. In clinical trials and real-use observational studies, the Pfizer-BioNTech BNT162b2 messenger RNA coronavirus disease 2019 vaccine, as well as the Moderna mRNA-1273 messenger RNA coronavirus disease 2019 vaccine, have demonstrated high efficacy and few adverse events.
CASE SUMMARY: A 20-year-old male college student in good health developed tinnitus and hematuria shortly after vaccination and progressed swiftly to a syndrome of: systemic inflammation; acute kidney injury requiring hemodialysis; acute, bilateral, complete sensorineural hearing loss; radiographic evidence of acute multifocal ischemic strokes; pericardial effusion complicated by tamponade physiology requiring pericardial evacuation; pleural effusions requiring evacuation; and systemic capillary leak. An extensive clinical and research investigation, including cytokine analysis, whole blood cytometry by time of flight, and whole exome sequencing, did not reveal a definitive explanatory mechanism.
CONCLUSION: While the overall safety profile of the BNT162b2 coronavirus disease 2019 vaccine remains excellent for the general population, rare serious events have been reported. In this report, we describe a case of multisystem inflammation and organ dysfunction of unknown mechanism beginning shortly after administration of the first dose of BNT162b2 coronavirus disease 2019 vaccine in a previously healthy recipient.
参考来源
- Kahn B, Apostolidis SA, Bhatt V, et al. Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination. Crit Care Explor. 2021. PMID: 34765984. doi:10.1097/CCE.0000000000000578
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。